ALAMEDA,
Calif., Dec. 30, 2024 /PRNewswire/ -- Penumbra,
Inc. (NYSE: PEN) today announced that its management team is
scheduled to present at the 43rd Annual J.P. Morgan
Healthcare Conference on Monday, January 13,
2025.
Event: 43rd Annual J.P. Morgan
Healthcare Conference
Date: Monday, January 13, 2025
Time: 6:00pm
ET/3:00pm PT
A webcast of the presentation can be accessed on the "Events and
Presentations" section under the "Investors" tab of the company's
website at www.penumbrainc.com. The webcast will be available
on the company's website for at least two weeks following the
event.
About Penumbra
Penumbra, Inc., the world's
leading thrombectomy company, is focused on developing the most
innovative technologies for challenging medical conditions such as
ischemic stroke, venous thromboembolism such as pulmonary embolism,
and acute limb ischemia. Our broad portfolio, which includes
computer assisted vacuum thrombectomy (CAVT), centers on removing
blood clots from head-to-toe with speed, safety and simplicity. By
pioneering these innovations, we support healthcare providers,
hospitals and clinics in more than 100 countries, working to
improve patient outcomes and quality of life. For more information,
visit www.penumbrainc.com and connect on Instagram, LinkedIn and
X.
Investor Relations
Penumbra, Inc.
investors@penumbrainc.com
View original content to download
multimedia:https://www.prnewswire.com/news-releases/penumbra-inc-to-present-at-the-43rd-annual-jp-morgan-healthcare-conference-302337761.html
SOURCE Penumbra, Inc.
